US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 21.000
  • -0.230-1.08%
Close Jul 19 16:00 ET
  • 21.000
  • 0.0000.00%
Pre 08:00 ET
3.25BMarket Cap70.00P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

63.47M

+713.46%
EPS(YoY)

-0.07

+75.00%
Analyst Rating

Buy

Jun 30, 2024

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 78.170M--
--2024/Q2-- / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--
Nov 1, 20232023/Q3165.815M / 63.337M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 78.170M--
--2024/Q2-- / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--
Nov 1, 20232023/Q3165.815M / 63.337M--

Unlock Free Earnings Estimates

TG Therapeutics Earnings Reports

  • TG Therapeutics | 10-Q: Quarterly report

    May 6 17:00 ET

  • TG Therapeutics | 10-K: Annual report

    Feb 29 17:29 ET

  • TG Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 17:01 ET

  • TG Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 4, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      16.67%

    • Sell

      16.67%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg